Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.

Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, Massironi S, Della Corte C, Ronchi G, Rumi MG, Biondetti P, Colombo M.

Gut. 2010 May;59(5):638-44. doi: 10.1136/gut.2009.187286. Epub 2009 Dec 1.

PMID:
19951909
2.

Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.

Manini MA, Sangiovanni A, Fornari F, Piscaglia F, Biolato M, Fanigliulo L, Ravaldi E, Grieco A, Colombo M; Study Participants.

J Hepatol. 2014 May;60(5):995-1001. doi: 10.1016/j.jhep.2014.01.006. Epub 2014 Jan 22.

PMID:
24462368
3.

CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.

Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, Lu DS.

Clin Gastroenterol Hepatol. 2011 Feb;9(2):161-7. doi: 10.1016/j.cgh.2010.09.017. Epub 2010 Oct 1.

PMID:
20920597
4.

CT and MRI of hepatocellular carcinoma: an update.

Ayyappan AP, Jhaveri KS.

Expert Rev Anticancer Ther. 2010 Apr;10(4):507-19. doi: 10.1586/era.10.24. Review.

PMID:
20397916
5.

Imaging of HCC.

Ayuso C, Rimola J, García-Criado A.

Abdom Imaging. 2012 Apr;37(2):215-30. doi: 10.1007/s00261-011-9794-x. Review.

PMID:
21909721
6.

[Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].

Helmberger T, Gregor M, Holzknecht N, Rau H, Scheidler J, Reiser M.

Rofo. 2000 Mar;172(3):251-9. German.

PMID:
10778456
7.

Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.

Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.

Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d.

PMID:
19838119
8.

Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.

J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.

PMID:
20657216
9.

Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation.

Kim SH, Choi BI, Lee JY, Kim SJ, So YH, Eun HW, Lee JM, Han JK.

Intervirology. 2008;51 Suppl 1:52-60. doi: 10.1159/000122598. Epub 2008 Jun 10. Review.

PMID:
18544949
10.

Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.

Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA.

J Magn Reson Imaging. 2010 Aug;32(2):360-6. doi: 10.1002/jmri.22271.

11.

Imaging of hepatocellular carcinoma and early diagnosis.

Limaye AR, Cabrera R.

Minerva Med. 2010 Dec;101(6):395-404. Review.

PMID:
21196899
12.

Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.

Rimola J, Forner A, Tremosini S, Reig M, Vilana R, Bianchi L, Rodríguez-Lope C, Solé M, Ayuso C, Bruix J.

J Hepatol. 2012 Jun;56(6):1317-23. doi: 10.1016/j.jhep.2012.01.004. Epub 2012 Feb 4.

PMID:
22314420
13.

[Imaging in the screening and diagnosis of hepatocellular carcinoma in cirrhosis liver in Tunisia. A series of 30 cases].

Ben Hassine L, Daghfous MH, Mami A, Chammakhi-Jemli C, Zouaoui W, Saddoud W, Miaoui A, Kharrat J, Ghorbal A, Sehili-Briki S.

Tunis Med. 2007 May;85(5):421-6. French.

PMID:
17657932
14.

Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.

Seitz K, Strobel D, Bernatik T, Blank W, Friedrich-Rust M, Herbay Av, Dietrich CF, Strunk H, Kratzer W, Schuler A.

Ultraschall Med. 2009 Aug;30(4):383-9. doi: 10.1055/s-0028-1109673. Epub 2009 Aug 17.

PMID:
19688670
15.

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J.

Hepatology. 2008 Jan;47(1):97-104. Erratum in: Hepatology. 2008 Feb;47(2):769.

PMID:
18069697
16.

Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.

D'Onofrio M, Faccioli N, Zamboni G, Malagò R, Caffarri S, Fattovich G, Mucelli RP.

Radiol Med. 2008 Oct;113(7):978-91. doi: 10.1007/s11547-008-0316-z. Epub 2008 Sep 8. English, Italian.

PMID:
18779929
17.

CT and MRI findings of cirrhosis-related benign nodules with ischaemia or infarction after variceal bleeding.

Kim YK, Park G, Kim CS, Han YM.

Clin Radiol. 2010 Oct;65(10):801-8. doi: 10.1016/j.crad.2010.05.004.

PMID:
20797466
18.

Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.

Tremolda F, Benevegnù L, Drago C, Casarin C, Cechetto A, Realdi G, Ruol A.

Hepatogastroenterology. 1989 Dec;36(6):519-21.

PMID:
2482242
19.

Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.

Hatanaka K, Kudo M, Minami Y, Maekawa K.

Oncology. 2008;75 Suppl 1:42-7. doi: 10.1159/000173423. Epub 2008 Dec 17.

PMID:
19092271
20.

Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.

Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW.

Acta Radiol. 2008 Sep;49(7):735-43. doi: 10.1080/02841850802120045.

PMID:
18608015

Supplemental Content

Support Center